Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,973
archived clinical trials in
High Cholesterol

The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
Metabolic And Atherosclerosis Research Center
mi
from
Cincinnati, OH
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
Metabolic And Atherosclerosis Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
Sterling Research Group, Ltd. - Auburn
mi
from
Cincinnati, OH
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
Sterling Research Group, Ltd. - Auburn
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
Columbus Clinical Research
mi
from
Columbus, OH
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
Columbus Clinical Research
mi
from
Columbus, OH
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
PSB Research/P. S. Bains, M.S., D.O.
mi
from
Marion, OH
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
PSB Research/P. S. Bains, M.S., D.O.
mi
from
Marion, OH
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
RAS Health
mi
from
Marion, OH
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
RAS Health
mi
from
Marion, OH
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
Lynn Health Science Institute - Oklahoma City
mi
from
Oklahoma City, OK
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
Lynn Health Science Institute - Oklahoma City
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
Willamette Valley Clinical Studies
mi
from
Eugene, OR
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
Willamette Valley Clinical Studies
mi
from
Eugene, OR
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
Green and Seidner Family Practice Associates
mi
from
Lansdale, PA
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
Green and Seidner Family Practice Associates
mi
from
Lansdale, PA
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
UnitedResearch - Orangeburg, LLC
mi
from
Orangeburg, SC
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
UnitedResearch - Orangeburg, LLC
mi
from
Orangeburg, SC
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
Padre Coast Clinical Research
mi
from
Corpus Christi, TX
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
Padre Coast Clinical Research
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
Advanced Clinical Research, Inc.
mi
from
West Jordan, UT
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
Advanced Clinical Research, Inc.
mi
from
West Jordan, UT
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
National Clinical Research - Norfolk, Inc.
mi
from
Norfolk, VA
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
National Clinical Research - Norfolk, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated:  10/7/2015
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects
Status: Enrolling
Updated: 10/7/2015
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Terence Hart, MD
mi
from
Muscle Shoals, AL
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Terence Hart, MD
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Pacific Oaks Medical Group
mi
from
Beverly Hills, CA
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Pacific Oaks Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
National Research Institute - Wilshire
mi
from
Los Angeles, CA
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
National Research Institute - Wilshire
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Research Across America - Santa Ana
mi
from
Santa Ana, CA
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Research Across America - Santa Ana
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Encompass Clinical Research
mi
from
Spring Valley, CA
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Encompass Clinical Research
mi
from
Spring Valley, CA
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Jacksonville Impotence Treatment Center
mi
from
Jacksonville, FL
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Jacksonville Impotence Treatment Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Compass Research East, LLC
mi
from
Oviedo, FL
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Compass Research East, LLC
mi
from
Oviedo, FL
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Progressive Medical Research
mi
from
Port Orange, FL
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Progressive Medical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Meridien Research
mi
from
St. Petersburg, FL
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Meridien Research
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Meridien Research- Tampa
mi
from
Tampa, FL
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Meridien Research- Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Evanston Premier Healthcare Research LLC
mi
from
Evanston, IL
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Evanston Premier Healthcare Research LLC
mi
from
Evanston, IL
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Medisphere Medical Research Center
mi
from
Evansville, IN
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Medisphere Medical Research Center
mi
from
Evansville, IN
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Heartland Research Assoc., LLC
mi
from
Newton, KA
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Heartland Research Assoc., LLC
mi
from
Newton, KA
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Louisville Metabolic and Atherosclerosis Research Center (L-MARC)
mi
from
Louisville, KY
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Louisville Metabolic and Atherosclerosis Research Center (L-MARC)
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Troy Internal Medicine, PC
mi
from
Troy, MI
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Troy Internal Medicine, PC
mi
from
Troy, MI
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Radiant Research - Edina
mi
from
Edina, MN
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Radiant Research - Edina
mi
from
Edina, MN
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Peters Medical Research
mi
from
HIgh Point, NC
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Peters Medical Research
mi
from
HIgh Point, NC
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
PMG Research of Raleigh, LLC
mi
from
Raleigh, NC
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
PMG Research of Raleigh, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Sterling Research Group, Ltd. - Auburn
mi
from
Cincinnati, OH
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Sterling Research Group, Ltd. - Auburn
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Metabolic And Atherosclerosis Research Center
mi
from
Cincinnati, OH
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Metabolic And Atherosclerosis Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Columbus Clinical Research
mi
from
Columbus, OH
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Columbus Clinical Research
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
PSB Research/P. S. Bains, M.S., D.O.
mi
from
Marion, OH
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
PSB Research/P. S. Bains, M.S., D.O.
mi
from
Marion, OH
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
RAS Health
mi
from
Marion, OH
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
RAS Health
mi
from
Marion, OH
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Willamette Valley Clinical Studies
mi
from
Eugene, OR
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Willamette Valley Clinical Studies
mi
from
Eugene, OR
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Green and Seidner Family Practice Associates
mi
from
Lansdale, PA
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Green and Seidner Family Practice Associates
mi
from
Lansdale, PA
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
Padre Coast Clinical Research
mi
from
Corpus Christi, TX
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
Padre Coast Clinical Research
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
National Clinical Research - Norfolk, Inc.
mi
from
Norfolk, VA
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
National Clinical Research - Norfolk, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated:  10/7/2015
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia
Status: Enrolling
Updated: 10/7/2015
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Christus Memorial Hospital
mi
from
Corpus Christi, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Christus Memorial Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Valley Baptist Family Medicine Residency Program
mi
from
Harlingen, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Valley Baptist Family Medicine Residency Program
mi
from
Harlingen, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Laredo Medical Group
mi
from
Laredo, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Laredo Medical Group
mi
from
Laredo, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
McAllen Family Medicine Residency Program
mi
from
McAllen, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
McAllen Family Medicine Residency Program
mi
from
McAllen, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Family Medicine Residency Program, Christus Santa Rosa Hospital
mi
from
San Antonio, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Family Medicine Residency Program, Christus Santa Rosa Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Dept Family & Community Medicine, UTHSCSA
mi
from
San Antonio, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Dept Family & Community Medicine, UTHSCSA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Predictors of Response to Fenofibrate
Pretreatment Genotyping at APOA5 and GCKR Loci and Response to Fenofibrate Therapy
Status: Enrolling
Updated:  10/11/2015
UAB Kirklin Clinic
mi
from
Birmingham, AL
Predictors of Response to Fenofibrate
Pretreatment Genotyping at APOA5 and GCKR Loci and Response to Fenofibrate Therapy
Status: Enrolling
Updated: 10/11/2015
UAB Kirklin Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials